No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Renovaro | 10-Q: Q1 2025 Earnings Report
Renovaro Biosciences Appoints Simon Tarsh as Interim CFO
Express News | Renovaro Issues Shareholder Letter and Provides Corporate Update
Express News | Renovaro Inc Files for Mixed Shelf Offering of up to $200 Mln- SEC Filing
Renovaro | 10-K/A: Annual report (Amendment)
12 Health Care Stocks Moving In Thursday's Intraday Session